Psychotropic Drugs
Utopias
Literature, Modern
Neuropharmacology
Biological Psychiatry
Psychiatry
Antipsychotic Agents
Mental Disorders
Serotonin Uptake Inhibitors
Antidepressive Agents
Parkinson's syndrome, depression and imipramine. A preliminary report. (1/83)
Patients with Parkinson's syndrome whose major symptoms are akinesis, rigidity, inertia, depression, irritability and failure of adaptation rather than tremor appear to benefit in a global way from therapy with imipramine. Patients without much over-all functional impairment do not show this improvement. The hypothesis is offered that motivation to move and ability to move are perhaps neurologically as well as psychologically related functions. (+info)Effects of a single experience on subsequent reactions to drugs. (2/83)
The activity of rats in an unfamiliar environment was studied in order to determine how far their reactions to an amphetamine-barbiturate mixture depended on whether or not they had been under the influence of this mixture while exposed to the same environment once before. The environment consisted of a Y-shaped runway, and the activity studied was the number of entries into the arms of the Y during a three-minute trial; the two trials took place three days apart. At the first trial the drug mixture practically doubled activity. At the second trial rats which had been under the influence of the drug mixture at the first trial were again made more active by the drug mixture, but the drug mixture did not increase the activity of rats which had received only saline at the first trial. These results showed that a single brief exposure to an unfamiliar environment can markedly affect subsequent reactions to drugs, and interactions of this kind may have to be taken into account when it is desired to use animals repeatedly in tests of the action of drugs on behaviour. The drug mixture also produced ataxia which was assessed quantitatively by measuring the variability of the "splay" of the rats' footprints; ataxia was unaffected by previous experience. (+info)DRUGS ARE NOT ENOUGH: SOME PRINCIPLES OF PSYCHOPHARMACOLOGY FOR GENERAL MEDICAL PRACTICE. (3/83)
There is no necessary antagonism between the judicious use of drugs and a psychotherapeutic approach to patients in general medical practice. A table is presented with a simple pragmatic classification of types of drugs for altering emotional and mental states. Three general principles are given for the use of such drugs, illustrated by examples of the use and misuse of tranquillizers.Some differentiation is made between sedatives and tranquillizers and between different types of tranquillizers, particularly with reference to the need to consider depressive features in patients. Suggestions are made for the use of drugs for mild depressions and for depressions accompanying organic disease.One may have to take an "experimental" approach to new drugs to determine which to them are of value in relation to the particular emotional states of one's own patients. (+info)TREATMENT OF PSYCHOSOMATIC DISORDERS. (4/83)
Goals, potentialities and limitations of treatment of psychosomatic disorders are reviewed. Removal of a disturbing psychosomatic symptom may be all that can be accomplished. The bulk of patients suffering from psychosomatic disorders should be treated by physicians other than psychiatrists. Difficulties arise, owing to differences in approach, when treatment is carried out by a general physician as well as a psychiatrist. In appraising the prospects of treatment, the age on examination, intelligence, duration of illness, degree of insight, nature of illness, environmental stress and personality structure of the patients should be considered. Psychiatric measures which have been employed include: electroconvulsive therapy, psychotropic drugs, hypnosis, drug abreaction, group therapy, supportive psychotherapy and psychoanalysis. Psychoanalysis provides the best understanding of the psychodynamics of psychosomatic illness but is, for a variety of reasons, applicable only to a small number of patients. Alternations and removal of disturbing symptoms can be accomplished by the other therapeutic means. (+info)FIXED-RATIO PUNISHMENT WITH CONTINUOUS REINFORCEMENT. (5/83)
Rats were reinforced with water for every bar-press and concurrently punished for every 10th or 20th bar-press. Punishment produced an initial suppression of responding followed by recovery. A slight change in the method of delivering punishment eventually led to a high response rate just after punishment, a low response rate just before punishment, and frequent intermediate pauses. The results are interpreted as showing that punishment became a safe signal and that the high rate of responding it released came to act as a conditioned aversive stimulus. The effects of amphetamine were consistent with this interpretation. Alcohol had the paradoxical effect of increasing pauses and depressing the low rate before punishment. (+info)SOME PHARMACOLOGICAL PROPERTIES OF THIOPROPERAZINE AND THEIR MODIFICATION BY ANTI-PARKINSONIAN DRUGS. (6/83)
The pharmacological properties of a phenothiazine derivative thioproperazine have been compared with those of chlorpromazine, and the modifications by some anti-Parkinsonian drugs of its actions on the central nervous system have been studied. Thioproperazine was less potent than chlorpromazine in lowering blood pressure and antagonizing adrenaline in the cat, in depressing respiratory rate in the rabbit, in producing hypothermia and analgesia and in reducing the minimum anaesthetic dose of hexobarbitone in mice, and in protecting rats from convulsions induced by tryptamine. It was roughly equipotent to chlorpromazine in reducing locomotor activity of mice. Thioproperazine was more potent than chlorpromazine in protecting grouped mice from the acute toxicity of dexamphetamine, in preventing the acute behavioural disturbances produced by dexamphetamine in the rat, in producing a state of experimental catatonia in the rat and in preventing the emetic action of apomorphine in the dog. Hyoscine, benztropine or promethazine greatly reduced the ability of thioproperazine to prevent behavioural changes due to dexamphetamine in the rat and also abolished symptoms of experimental catatonia produced by thioproperazine. In contrast, the antiapomorphine activity of thioproperazine in the dog was not reduced to any extent by hyoscine or benztropine. (+info)SCIENCE, MYSTICISM AND PSYCHOPHARMACOLOGY. (7/83)
Historically, psychopharmaceutical agents have been used to produce a mystical state with the religious connotation of "a union with Divine Nature" or of "oneness with God." Such transcendental states are also known to occur in starvation, self-flagellation, Yoga and various psychoses.A common psychological origin is suggested for these states, in which there is a psychic regression to an early phase of development. This genetically is the phase wherein the infant is still united with the mother and has not yet established the boundaries between the "self" and the "not-self." In a subtler form, the desire to regress to this phase may be a universal yearning which affects the physician, the investigator and even the manufacturer of drugs. Accordingly, we have a profusion of tranquilizers, euphoriants and ataractics the prescription or the investigation of which may give vicarious pleasure and relief of tension to the physician and scientist by a process of identification with the person receiving the drug.Mankind's quest for psychic development is difficult and precarious, alternately marked by progression and regression. Excesses in the use of drugs are indicated as regressive in nature. (+info)THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY. (8/83)
One hundred of 150 patients with non-psychotic functional psychiatric disorders were benefited by the use of LSD psychotherapy. The dosage of LSD employed was 25 to 2000 micrograms intramuscularly per session for from one to 10 sessions. On this regimen four patients became psychotic and required electroconvulsive therapy. None were permanently harmed.Indications for and contraindications to this form of treatment and a procedure involving a doctor and a nurse as co-therapists are discussed. In particular, LSD is considered to permit "perceptualization of the transference".LSD possibly extends the scope and value of the psychotherapeutic approach in such cases. (+info)Psychopharmacology is a branch of psychopharmacology that deals with the study of the effects of drugs on mood, thinking, and behavior. It involves researching how various substances interact with the brain and nervous system to produce changes in perception, cognition, consciousness, and emotion. This field also includes the development and testing of medications used to treat mental disorders, as well as the study of the potential misuse and abuse of drugs. Psychopharmacologists may work in academia, research institutions, or the pharmaceutical industry, and they often collaborate with other healthcare professionals, such as psychiatrists and neurologists, to develop and implement treatment plans for patients.
Psychotropic drugs, also known as psychoactive drugs, are a class of medications that affect the function of the central nervous system, leading to changes in consciousness, perception, mood, cognition, or behavior. These drugs work by altering the chemical neurotransmitters in the brain, such as dopamine, serotonin, and norepinephrine, which are involved in regulating mood, thought, and behavior.
Psychotropic drugs can be classified into several categories based on their primary therapeutic effects, including:
1. Antipsychotic drugs: These medications are used to treat psychosis, schizophrenia, and other related disorders. They work by blocking dopamine receptors in the brain, which helps reduce hallucinations, delusions, and disordered thinking.
2. Antidepressant drugs: These medications are used to treat depression, anxiety disorders, and some chronic pain conditions. They work by increasing the availability of neurotransmitters such as serotonin, norepinephrine, or dopamine in the brain, which helps improve mood and reduce anxiety.
3. Mood stabilizers: These medications are used to treat bipolar disorder and other mood disorders. They help regulate the ups and downs of mood swings and can also be used as adjunctive treatment for depression and anxiety.
4. Anxiolytic drugs: Also known as anti-anxiety medications, these drugs are used to treat anxiety disorders, panic attacks, and insomnia. They work by reducing the activity of neurotransmitters such as GABA, which can help reduce anxiety and promote relaxation.
5. Stimulant drugs: These medications are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. They work by increasing the availability of dopamine and norepinephrine in the brain, which helps improve focus, concentration, and alertness.
It is important to note that psychotropic drugs can have significant side effects and should only be used under the close supervision of a qualified healthcare provider.
I'm sorry for any confusion, but "utopias" is not a term that has a medical definition. Utopia is a concept from literature and philosophy, representing an ideal or perfect society or community. It may refer to a place, state, or situation in which everything is perfect. If you have any questions related to medicine or healthcare, I'd be happy to try to help answer those for you!
I'm happy to help! However, it seems there might be a bit of confusion in your question. "Modern" is a term that refers to a period in time, specifically the modern period which is generally considered to be from the late 19th century to the present. "Literature," on the other hand, is a broad term that refers to written works, especially those considered to have artistic or intellectual value.
So, when you ask for a medical definition of "Literature, Modern," it's not entirely clear what you are looking for. If you are asking for examples of modern literature that deal with medical themes or issues, there are many notable works to choose from, including:
* "The Immortal Life of Henrietta Lacks" by Rebecca Skloot, which explores the ethical implications of medical research using human cells without consent.
* "The Hot Zone" by Richard Preston, a thriller about the Ebola virus and its potential to cause a global pandemic.
* "Complications: A Surgeon's Notes on an Imperfect Science" by Atul Gawande, a collection of essays that examine the challenges and uncertainties of medical practice.
* "Brain on Fire: My Month of Madness" by Susannah Cahalan, a memoir about the author's experience with a rare autoimmune disorder that affected her brain.
If you are looking for something else, please let me know and I will do my best to assist you!
Neuropharmacology is a branch of pharmacology that deals with the study of how drugs affect the nervous system and its cells or organs. It involves investigating the interactions between neurochemical communication systems, such as neurotransmitters and neuromodulators, and drugs that alter their function. This field also includes understanding the effects of drugs on behavior, cognition, and other neurological processes. Neuropharmacology can be further divided into two main areas: behavioral neuropharmacology, which focuses on the study of drugs that affect behavior, and molecular neuropharmacology, which deals with the molecular and cellular mechanisms of drug action in the nervous system.
Biological psychiatry is a branch of medicine that aims to understand and treat mental disorders by studying the biological mechanisms underlying behavior, cognition, and emotion. This can include the study of genetics, neurochemistry, brain structure and function, and other physiological processes that may contribute to the development and expression of mental illnesses.
Biological psychiatrists use a variety of approaches to understand and treat mental disorders, including psychopharmacology (the use of medications to treat psychiatric symptoms), neurostimulation techniques (such as electroconvulsive therapy or transcranial magnetic stimulation), and behavioral interventions (such as cognitive-behavioral therapy).
The ultimate goal of biological psychiatry is to develop more effective treatments for mental illnesses by gaining a deeper understanding of the underlying biological mechanisms that contribute to their development and expression.
Psychiatry is the branch of medicine focused on the diagnosis, treatment, and prevention of mental, emotional, and behavioral disorders. A psychiatrist is a medically trained doctor who specializes in psychiatry, and they are qualified to assess both the mental and physical aspects of psychological problems. They can use a variety of treatments, including psychotherapy, medications, psychoeducation, and psychosocial interventions, to help patients manage their symptoms and improve their quality of life.
Psychiatrists often work in multidisciplinary teams that include other mental health professionals such as psychologists, social workers, and mental health nurses. They may provide services in a range of settings, including hospitals, clinics, community mental health centers, and private practices.
It's important to note that while I strive to provide accurate and helpful information, my responses should not be used as a substitute for professional medical advice, diagnosis, or treatment. If you or someone else has concerns about mental health, it is always best to consult with a qualified healthcare provider.
Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).
First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.
Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.
Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.
A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.
Serotonin uptake inhibitors (also known as Selective Serotonin Reuptake Inhibitors or SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. They work by increasing the levels of serotonin, a neurotransmitter in the brain that helps regulate mood, appetite, and sleep, among other functions.
SSRIs block the reuptake of serotonin into the presynaptic neuron, allowing more serotonin to be available in the synapse (the space between two neurons) for binding to postsynaptic receptors. This results in increased serotonergic neurotransmission and improved mood regulation.
Examples of SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications are generally well-tolerated, with side effects that may include nausea, headache, insomnia, sexual dysfunction, and increased anxiety or agitation. However, they can have serious interactions with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting an SSRI.
Antidepressive agents are a class of medications used to treat various forms of depression and anxiety disorders. They act on neurotransmitters, the chemical messengers in the brain, to restore the balance that has been disrupted by mental illness. The most commonly prescribed types of antidepressants include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). These medications can help alleviate symptoms such as low mood, loss of interest in activities, changes in appetite and sleep patterns, fatigue, difficulty concentrating, and thoughts of death or suicide. It is important to note that antidepressants may take several weeks to reach their full effectiveness and may cause side effects, so it is essential to work closely with a healthcare provider to find the right medication and dosage.
Psychopharmacology - Wikipedia
UCL Psychopharmacology Unit
Psychopharmacology Committee Member (two vacancies)
International Clinical Psychopharmacology
Statistical methodologies in psychopharmacology: a review
Cosmetic psychopharmacology
Post-Prozac: American Psychopharmacology, the Morning After | Observer
API Announces 6th Annual Master Psychopharmacology Conference: Master Consultations to Answer Psychiatrists' 'Burning Questions'
APA - Psychodynamic Psychopharmacology
APA - Psychodynamic Psychopharmacology
The Creation of Psychopharmacology | Psychiatrist.com
Current Psychopharmacology | Bentham Science
Current Psychopharmacology | Bentham Science
ISSN 1432-2072 (Online) | Psychopharmacology | The ISSN Portal
Antidepressants - Slideset Download - Psychopharmacology 2022 | CCO
Psychopharmacology for the Integrated Behavioral Health Professional | Denver Health
psychopharmacology · School of Pharmacy · UCSF
Pediatric Psychopharmacology for Primary Care | R2 Digital Library
Professional Ethics and Psychopharmacology | Units of study... | Swinburne University of Technology | Melbourne, Australia
Psychopharmacology, Medications & Treatment Registration Confirmation | Family Service
Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study |...
This Month in Psychopharmacology
Current Psychopharmacology | Bentham Science
This Month in Psychopharmacology
Psychopharmacology: A Concise Overview for Students and Clinicians, 2nd Edition
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques |...
The Latest in Psychopharmacology Medical Education on ReachMD
Turkish Association for Psychopharmacology (TAP)
Erowid.org: Erowid Reference 1280 : Human psychopharmacology of ecstasy; A review of 15 years of empirical research : Parrott AC
Neurochemistry & Psychopharmacology (Lecture Notes) - Flashcard Maker
Cosmetic psychopharmacology7
- A dvances in neuroscience and biotechnology have heightened the urgency of the debate over "cosmetic psychopharmacology," the use of drugs to enhance mood and temperament in the absence of illness. (biopsychiatry.com)
- Beyond Therapy: Biotechnology and the Pursuit of Happiness (2003), the report of the President's Council on Bioethics, has criticized the use of cosmetic psychopharmacology. (biopsychiatry.com)
- The Council claimed that cosmetic psychopharmacology will necessarily lead to "severing the link between feelings of happiness and our actions and experiences in the world," but it provided no satisfactory arguments to support this claim and ignored the possibility that cosmetic psychopharmacology might actually enhance the link between happiness and experience. (biopsychiatry.com)
- The Council's arguments against cosmetic psychopharmacology depend heavily on the mistaken belief that Prozac and similar antidepressants are mood brighteners in healthy subjects. (biopsychiatry.com)
- The empirical evidence, however, clearly indicates that these drugs are not forms of cosmetic psychopharmacology, thus negating much of the Council's arguments. (biopsychiatry.com)
- This is a morning-after kind of book, a sober, light-of-day treatise determined to puncture the myths behind our love affair with "cosmetic psychopharmacology. (observer.com)
- It is insteada well-written story of a stream of convenient accidents,of technical discoveries, of blistering professional competitions,of the growth and power of the pharmaceutical industry,of the delineation of psychiatric 'disease,' of regulation, and ofthe emerging cosmetic psychopharmacology and managementof personality. (psychiatrist.com)
Child and Adolescent Psychopharmacology3
- The course is taught in conjunction with the Advanced Seminar in Child and Adolescent Psychopharmacology (Psychiatry 261). (ucla.edu)
- 6th International Psychopharmacology and 2nd Child and Adolescent Psychopharmacology Symposium began November 4, 2013 the date of registration and accommodation references. (psikofarmakoloji.org)
- Dear Colleagues, 6th International Congress on Psychopharmacology & 2nd International Symposium on Child and Adolescent Psychopharmacology (6th ICP - 2nd ISCAP) of TURKISH ASSOCIATION FOR PSYCHOPHARMACOLOGY will be held in Antalya between 16 and 20 April 2014. (psikofarmakoloji.org)
Psychiatry and Clinical Psychopharmacology1
- Psychiatry and Clinical Psychopharmacology (formerly Bulletin of Clinical Psychopharmacology 1990-2016) is an international, scientific, open access, online-only periodical published in accordance with independent, unbiased, and double-blinded peer-review principles. (psikofarmakoloji.org)
Neuroscience2
- Clinical Psychopharmacology and Neuroscience Papers in Press available online. (cpn.or.kr)
- Anyone prescribing medications to treat patients with mental health problems needs to have detailed knowledge of topics such as neuroscience, clinical medicine, and psychopharmacology in addition to their expertise in diagnosing and treating psychiatric illnesses. (barryjrichmanmd.com)
Creation of Psychopharmacology4
- The Creation of Psychopharmacology is an engaging exposéof the development of Western psychopharmacology. (psychiatrist.com)
- The Creation of Psychopharmacology by David Healy. (docdiller.com)
- His major work to date is The Creation of Psychopharmacology , a 469 page heavy weight, which initially is not easy reading, even for a doctor, but rewards the reader with an erudite, well thought out, broad conclusion about the drug companiesí influence on the way we think of ourselves and how we deal with our problems. (docdiller.com)
- In any case, any one interested in learning about the economic factors involved in psychiatric diagnosis and treatment would be advised to read The Creation of Psychopharmacology . (docdiller.com)
Neuropsychology and Psychopharmacology1
- Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology and psychopharmacology. (pesi.com.au)
Clinical7
- Thought you might appreciate this item(s) I saw in International Clinical Psychopharmacology. (lww.com)
- Click on the link below to submit your manuscript to International Clinical Psychopharmacology . (lww.com)
- Today, the overall results of six Phase 2 clinical trials of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) were published in the peer-reviewed journal Psychopharmacology . (maps.org)
- The Douglas M. Berger Psychopharmacology Research Fellowship in Japan is designed to provide support for young researchers to study a clinical psychopharmacology topic in collaboration with a Japanese host scientist. (japanpsychiatrist.com)
- The host's acceptance letter should include the contacts of the host, and indicate that the Fellow will be supported by the Douglas M. Berger Clinical Psychopharmacology Research Fellowship in Japan including the total amount of the support to be received from the Fellowship. (japanpsychiatrist.com)
- Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated psychopharmacology workshops to clinicians throughout the United States since 2010. (pesi.com.au)
- Establish ethical issues specifically relating to the limits of non-prescribers'' discussion of medications as it relates to clinical psychopharmacology. (pesi.com.au)
Psychology1
- If you are at an impasse with your patients despite optimal psychopharmacology, in all likelihood the problem is not with the biology but with the powerful psychology of the person and the therapist. (appi.org)
Search2
- Results of search for 'su:{Psychopharmacology. (who.int)
- Existe limitada información respecto al uso de search of information in cannabidiol en enfermedades neurodegenerativas, por lo que no se ha evidenciado su efectividad. (bvsalud.org)
Psychiatric2
- The purpose of the Fellowship is to promote international friendship as well as to further the study of psychopharmacology in the hopes that study of this nature can help patients with psychiatric illness. (japanpsychiatrist.com)
- Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration background. (bvsalud.org)
Expertise3
- It also provides a focus of expertise in the area of psychopharmacology in the College. (rcpsych.ac.uk)
- To provide a focus of expertise about psychopharmacology in the College. (rcpsych.ac.uk)
- Play a key role in providing expertise in psychopharmacology. (rcpsych.ac.uk)
Clinicians2
- Participants will also have the opportunity to learn more about the history of psychopharmacology and early interventions used, as well as, engage in a pertinent discussion on the ethical issues clinicians face as they integrate with primary care. (denverhealth.org)
- Overall, I believe the Ansari-Osser text is well-suited to the needs of medical students, early-career clinicians, and other mental health professionals who desire a concise but constructively critical overview of psychopharmacology. (psychiatrictimes.com)
Mental health di1
- Psychopharmacology is a field of medicine that focuses on the use of medications for treating patients who have mental health disorders. (barryjrichmanmd.com)
Medications2
- What kinds of medications are used in psychopharmacology? (barryjrichmanmd.com)
- Many different medications may be used in psychopharmacology. (barryjrichmanmd.com)
Primary care1
- Elizabeth Lowdermilk, MD - Dr. Lowdermilk is a board certified psychiatrist at Denver Health and subject matter expert for classroom training curricula on psychopharmacology in primary care. (denverhealth.org)
Council1
- An opportunity has arisen for two committee members to join the membership of the Psychopharmacology Committee of Council. (rcpsych.ac.uk)
Advocacy1
- Mr. Catir has a particular interest in psychopharmacology and homeless advocacy and has worked for several years with the Colorado Coalition for the Homeless. (denverhealth.org)
Practice3
- The committee is responsible for ensuring the College guidance and policy in the field of psychopharmacology remains up to date and reflects best practice. (rcpsych.ac.uk)
- The prevailing objective of this investigation has been study the psychologist's value, in their professional practice, about the relation between the psychopharmacology and the psychopharmacotherapy. (bvsalud.org)
- and 3) theoretical and technical orientation underlying the professional practice / opinion upon professional upgrade on psychopharmacology. (bvsalud.org)
Treatment2
- It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. (appi.org)
- This 4-hour psychopharmacology training is perfect for new Masters' or PhD level behavioral health providers, or those looking for a refresher on basic pharmacologic treatment strategies for major mental health diagnoses. (denverhealth.org)
Meetings1
- Attend the meetings of the Psychopharmacology Committee, which may be held 3 times per year at the College, elsewhere or online. (rcpsych.ac.uk)
Research3
- The Douglas M. Berger Psychopharmacology Research Fellowship in Japan will provide a total of 1.0 million yen (approximately US $11,000 depending on the exchange rate) for the fellowship under the following conditions. (japanpsychiatrist.com)
- Psychopharmacology entails an extensive research in a broad range of drug classes including stimulants and antidepressants. (farmastan.com)
- Los efectos del cannabidiol lo convierten en una alternativa, of the title and research adicional a la terapéutica convencional, para el control de síntomas en trastornos neurológicos, disminuyendo de forma objectives, exhaustive sostenida el número total de episodios con un perfil de seguridad aceptable. (bvsalud.org)
Medication1
- In addition to being a skilled psychotherapist , Dr. Richman is also an experienced NYC psychopharmacology doctor who knows when to intervene with medication for the best outcome and for the benefit of his patients. (barryjrichmanmd.com)
Conference2
- Attendees may register online by visiting http://www.masterpsych.com/master-psychopharmacology-conference-2015.html , or calling 877-225-8384 . (prnewswire.com)
- We invite you to join us at the Westin Copley Place in Boston for our annual Psychopharmacology conference. (mghcme.org)
Text1
- In 2000, Dr. Stephen Stahl published what many of us consider to be the definitive text of psychopharmacology. (reachmd.com)
Main1
- This review aims to describe the main topics related to statistical methods in psychopharmacology, namely nature of statistics in medicine, problems in data analysis, statistical modelling, developments in statistical technology, statistical reporting and meta-analysis. (nih.gov)
Professional1
- This unit of study has two six week components - advanced professional ethics and psychopharmacology. (edu.au)
Book2
- By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. (appi.org)
- Throughout the book, there is a "point/counterpoint" approach to the material-and let me say at once that this is a very good thing in psychopharmacology, where dogmatic statements and bumper sticker recommendations are all too common. (psychiatrictimes.com)
Work1
- The second edition of Ansari and Osser's overview of psychopharmacology might well be subtitled, Sic et Non (after philosopher Peter Abelard's classic work) or, perhaps, On the Other Hand. (psychiatrictimes.com)
Second edition1
- Ronald Pies, MD reviews the second edition of Ansari and Osser's overview of psychopharmacology. (psychiatrictimes.com)
Patients1
- Within this group, epilepsy is refractory in up to 40 % of patients, who have shown para el control de síntomas refractarios en a decrease in the frequency of seizures with the concomitant use of cannabidiol and conventional antiepileptics, with mild síndromes convulsivos side effects such as diarrhea and drowsiness. (bvsalud.org)
Path1
- Psychodynamic Psychopharmacology illuminates a new path forward. (appi.org)